Skip to content

Erasca, Inc. ERAS Free cash flow

Free cash flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$757M-55.3%
Eli Lilly logo
Eli LillyLLY
$3.01B+1,828%
Pfizer logo
PfizerPFE
$2.18B+23.0%
Amgen logo
AmgenAMGN
$1.48B+50.7%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$355.7M-79.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$44.36M-6.3%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Calculated from Erasca, Inc.’s reported figures.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s free cash flow?
Erasca, Inc. (ERAS) reported free cash flow of -$27.42M in Q1 2026.
How has Erasca, Inc.'s free cash flow changed year-over-year?
Erasca, Inc.'s free cash flow increased by 13.3% year-over-year, from -$31.64M to -$27.42M.
What is the long-term trend for Erasca, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Erasca, Inc.'s free cash flow has grown at a 1.3% compound annual growth rate (CAGR), from -$90.81M to -$95.58M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.